Platelet eicosanoids and the effect of captopril in blood pressure regulation

European Journal of Pharmacology

Volumn 340, Issue 1, 1997, Pages 67-73

  Mezei, Zsófia ^a   Kis, Béla ^a   Gecse, Árpád ^a   Telegdy, Gyula ^a   Ábrahám, György ^a   Sonkodi, Sándor ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

12 L Hydroxy 5,8,10 heptadecatrienoic acid; Captopril; Lipoxygenase metabolite; Platelet; Spontaneously hypertensive rat (SHR); Thromboxane

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; CAPTOPRIL; ICOSANOID; LIPOXYGENASE; PROSTAGLANDIN B2; PROSTAGLANDIN D2; PROSTAGLANDIN SYNTHASE; THROMBOXANE;

ANIMAL CELL; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOCYTE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARACHIDONIC ACID; BLOOD PLATELETS; BLOOD PRESSURE; CAPTOPRIL; EICOSANOIDS; FATTY ACIDS, UNSATURATED; HYPERTENSION; LIPOXYGENASE; MALE; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED SHR; RATS, WISTAR; THROMBOXANES;

EID: 0031553372     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01402-7     Document Type: Article

References (39)

1. Abdel-Halim M.S., Lundén I., Cseh G., Angard E. Prostaglandin profiles in nervous tissue and blood vessels of the brain of various animals. Prostaglandins. 19:1980;249-258.
2. Abe K., Ito T., Sato M., Haruyama T., Sato K., Omata K., Hiwatari M., Sakurai Y., Imai Y., Yoshinaga K. Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension. Clin. Sci. 59:1980;141s-144s.
3. Bernard B., Volker U. 12-Hydroperoxyeicosatetraenoic acid inhibits main platelet functions by activation of soluble guanylate cyclase. Mol. Pharmacol. 39:1991;671-678.
4. Carretero O.A., Scicli A.G. Local hormonal factors (intracrin, autocrin, and paracrin) in hypertension. Hypertension. 18(3S):1991;158-169.
5. Chapleau M.W., Hajduczok G., Abbound F.M. Paracrine role of prostanoids in activation of arterial baroreceptors - An overview. Clin. Exp. Hypert. A Theory Pract. 13:1991;817-824.
6. David-Dufilho M., Koutouzov S., Marche P., Pernollet M.-G., Le Quan Sang H., De Mendonca M. Structural and functional alterations of the cell membrane in the prehypertensive rat of the Okamoto Aoki strain. J. Hypertension. 4:1986;S263-S265.
7. Düsing R., Scherhag R., Landsberg G., Glanzer K., Kramer H.J. The converting enzyme inhibitor captopril stimulates prostacyclin synthesis by isolated rat aorta. Eur. J. Pharmacol. 91:1983;501-504.
8. Dzau V.J., Swartz S.L. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease. Am. J. Cardiol. 6:1987;1101-1105.
9. Ganten G. The renin-angiotensin paradigm. Practical therapeutical consequences of basic research. Arzneim. Forsch. Drug Res. 43:1993;191-197.
10. Gecse Á., Telegdy Gy. Captopril as a modifier of the arachidonate cascade of rat platelets. Agent Act. Suppl. 38:1992;201-208.
11. Goldfarb D.A. The renin-angiotensin system. New concepts in regulation of blood pressure and renal function. Urol. Clin. North Am. 21:1994;187-194.
12. Huzoor A., Kundu N., Kornhauser R. Normal thrombin binding leads to greater fibrinogen binding and increased platelet aggregation in spontaneously hypertensive rats. Life Sci. 53:1993;1967-1974.
13. Ishida-Kainouchi M., Matsuura H., Ishida T., Kajiyama G., Oshima T. Platelet calcium handling in spontaneously hypertensive rats and in three strains of normotensive rats. J. Hypertension. 11:1993;509-514.
14. Islim I.F., Bareford D., Ebanks M., Beevers D.G. The role of platelets in essential hypertension. Blood Press. 4:1995;199-214.
15. James I.M., Dickinson E.J., Burgoyne W., Jeremy J.Y., Barradar M.A., Mikhailidis D.P. Treatment of hypertension with captopril: Preservation of regional blood flow and reduced platelet aggregation. J. Hum. Hypertens. 2:1988;21-25.
16. Kiefer H.C., Johson C.R., Arora K.L. Colorimetric identification of prostaglandins in subnanomole amounts. Anal. Biochem. 68:1975;336-340.
17. Kjeldsen S.E., Zweifler A.J., Petrin J., Weder A.B., Julius S. Sympathetic nervous system involvement in essential hypertension: increased platelet noradrenaline coincides with decreased beta-adrenoceptor responsiveness. Blood Press. 3:1994;164-171.
18. Kobayashi T., Levine L. Arachidonic acid metabolism by erythrocytes. J. Biol. Chem. 258:1983;9116-9121.
19. Kripalani K.J., McKinstry D.N., Singhvi S.M., Qillard D.A., Vukovich R.A., Migdalof B.H. Disposition of captopril in normal subjects. Clin. Pharm. Ther. 27:1980;636-641.
20. Krzesinski J.M., Du F., Rorive G. Intracellular cation concentrations in essential hypertension and chronic renal failure. Clin. Exp. Hypertens. 15:1993;461-478.
21. Laragh J.H. The renin system and new understanding of the complications of hypertension and their treatment. Arzneim. Forsch. Drug Res. 43:1993;247-254.
22. Lemne C., Vesterqvist O., Egberg N., Green K., Jogestrand T., de-Faire U. Platelet activation and prostacyclin release in essential hypertension. Prostaglandins. 44:1992;219-235.
23. Nityanand S., Pande I., Bajpai V.K., Singh L., Chandra M., Singh B.N. Platelets in essential hypertension. Thromb. Res. 72:1993;447-454.
24. Okamoto K., Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27:1963;282-293.
25. Sadowitz P.D., Yamaja Setty B.N., Stuart M. 12-HHT as an endogenous regulator of prostacyclin synthesis. Prostaglandins. 34:1987;749-763.
26. Santucci A., Ferri C., Luparini R.L., Del Porto M.A., De Angelis C., Ficara C., Balsano F. Effect of angiotensin converting enzyme inhibition on platelet angiotensin II content. Am. J. Med. 84(S3A):1988;119-121.
27. Scharpé S.L., Vanhoof G.C., De Meester I.A., Hendriks D.F., van Sande M.E., Muylle L.M., Yaron A. Exopeptidases in human platelets: An indication for proteolytic modulation of biologically active peptides. Clin. Chim. Acta. 195(3):1990;125-131.
28. Schirner M., Taube C. Different effects of aspirin on blood pressure of spontaneously hypertensive rats (SHR) with high and spontaneously low levels of blood pressure. Br. J. Pharmacol. 109:1993;900-901.
29. Schrör K. Prostaglandin-mediated actions of the renin-angiotensin system. Arzneim. Forsch. Drug Res. 43:1993;236-241.
30. 2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodinamic response to captopril in chronic congestive heart failure. Cardiology. 70:1983;297-307.
31. Smith S.R., Coffman T.M., Svetkey L.P. Effect of low-dose aspirin on thromboxane production and the antihypertensive effect of captopril. J. Am. Soc. Nephrol. 4:1993;1133-1139.
32. Snyder R.A., Watt K.W.K., Wintroub B.U. A human platelet angiotensin I-processing system. Identification of components and inhibition of angiotensin-converting enzyme by product. J. Biol. Chem. 260:1985;7857-7860.
33. 10-angiotensin I: A potencial mechanism of endogenous angiotensin-converting enzyme regulation. Biochim. Biophys. Acta. 871:1986;1-5.
34. Stern N., Kisch E.S., Knoll E. Platelet lipoxygenase in spontaneously hypertensive rats. Hypertension. 27:1996;1149-1152.
35. Swartz S.L., Williams G.H. Angiotensin-converting enzyme inhibition and prostaglandins. Am. J. Cardiol. 49:1982;1405-1409.
36. Van Gils W.H., Van Wijngaarden J., Scholtens E., De Graeff P.A., De Langen C.D.J., Wesseling H. Captopril-induced increase in coronary flow: An SH-dependent effect on arachidonic acid metabolism? J. Cardiovasc. Pharm. 9:1987;S31-S36.
37. Vanhoutte P.M., Boulanger C.M., Illiano S.C., Nagao T., Vidal M., Mombouli J.-V. Endothelium-dependent effects of converting-enzyme inhibitors. J. Cardiovasc. Pharm. 22:1993;S10-S16.
38. 2+ concentrations and on suppression of cell proliferation in culture. J. Tonfii. Med. Univ. 13:1993;183-185.
39. Witzgall H., Hirsch F., Scherer B., Weber P.C. Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin. Clin. Sci. 62:1982;611-615.